| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 09/23/2004 | CA2518886A1 Method for treating mild cognitive impairment and for preventing or delaying alzheimer's disease |
| 09/23/2004 | CA2518883A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 09/23/2004 | CA2518475A1 Irna agents comprising asymmetrical modifications |
| 09/23/2004 | CA2518407A1 Animal model simulating neurologic disease |
| 09/23/2004 | CA2518357A1 Method of treating cancer with azaspirane compositions |
| 09/23/2004 | CA2518329A1 Rapidly absorbing lipophilic skin compositions and uses therefor |
| 09/23/2004 | CA2518275A1 Humanized antibodies that recognize beta amyloid peptide |
| 09/23/2004 | CA2518216A1 Oral insulin therapies and protocol |
| 09/23/2004 | CA2516919A1 Influenza virus vaccine |
| 09/23/2004 | CA2515286A1 Immunogenic cd19 ligand-antigenic molecule complexes and fusion proteins |
| 09/22/2004 | EP1460075A1 Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives |
| 09/22/2004 | EP1458690A1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 09/22/2004 | EP1458689A1 Aryloxyphenyl and arylsulfanylphenyl derivatives |
| 09/22/2004 | EP1458687A2 Pyrimidine compounds |
| 09/22/2004 | EP1458677A1 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
| 09/22/2004 | EP1458407A1 Liquid composition of modified factor vii polypeptides |
| 09/22/2004 | EP1458376A1 Darifenacin for use in the treatment of urgency induced by overactive bladder |
| 09/22/2004 | EP1458359A1 Microemulsion preconcentrate |
| 09/22/2004 | EP1187629B1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 09/22/2004 | EP1047388B1 Dyeing composition for keratinous fibres with a direct cationic colouring agent and an anionic surfactant |
| 09/22/2004 | CN1167423C Means for treating radiation injuries |
| 09/22/2004 | CN1167411C Betain agent for preparing aqueous cosmetic composition for treating skin |
| 09/21/2004 | US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists |
| 09/21/2004 | US6793946 Tea comprsing persea americana var. drymifolia leaves |
| 09/16/2004 | WO2004078147A2 Oxytocin controlled release formulations and methods of using same |
| 09/16/2004 | WO2004078146A2 Trans-membrane-antibody induced inhibition of apoptosis |
| 09/16/2004 | WO2004078145A2 Combination therapy with glatiramer acetate and simvastatin for the treatment of multiple sclerosis |
| 09/16/2004 | WO2004078144A2 Diphenylethylene compounds and uses thereof |
| 09/16/2004 | WO2004078143A2 Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs |
| 09/16/2004 | WO2004078141A2 Hemipteran membrane-bound matrix metalloproteinase |
| 09/16/2004 | WO2004078140A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 09/16/2004 | WO2004078137A2 Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 09/16/2004 | WO2004078136A2 Pyridinium salts, compounds and methods of use |
| 09/16/2004 | WO2004078135A2 LIGANDS THAT BIND TO THE AMYLOID-β PRECURSOR PEPTIDE AND RELATED MOLECULES AND USES THEREOF |
| 09/16/2004 | WO2004078132A2 Automated insomnia treatment system |
| 09/16/2004 | WO2004078131A2 Evaluating effects of exposure conditions on drug samples over time |
| 09/16/2004 | WO2004078130A2 Posh interacting proteins and related methods |
| 09/16/2004 | WO2004078128A2 Substituted pyridine derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | WO2004078127A2 Continuous delivery methods for treating hepatitis virus infection |
| 09/16/2004 | WO2004078126A2 Compositions and methods with enhanced therapeutic activity |
| 09/16/2004 | WO2004078125A2 Aerosol antiperspirant with polyamide |
| 09/16/2004 | WO2004078123A2 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use |
| 09/16/2004 | WO2004078122A2 Invisible patch for active agnet controlled delivery |
| 09/16/2004 | WO2004078120A2 Collagen compositions and biomaterials |
| 09/16/2004 | WO2004078119A2 Substituted thiophenes with antibacterial activity |
| 09/16/2004 | WO2004078118A2 Protein kinase c inhibitor, related composition, and method of use |
| 09/16/2004 | WO2004078116A2 P38 inhibitors and methods of use thereof |
| 09/16/2004 | WO2004078115A2 Benzothiazole compounds, compositions and methods for treatment and prophylaxis of rotavirus infections and associated diseases |
| 09/16/2004 | WO2004078114A2 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists. |
| 09/16/2004 | WO2004078111A2 Extended release minocycline compositions and processes for their preparation |
| 09/16/2004 | WO2004062627A9 In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders |
| 09/16/2004 | WO2004062592A3 2-o sulfatase compositions and related methods |
| 09/16/2004 | WO2004062576A3 Methods for treating ocular diseases |
| 09/16/2004 | WO2004062562A3 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 09/16/2004 | WO2004062557A3 Pharmaceutical combination of telmisartan and atorvastatin for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 09/16/2004 | WO2004058148A3 Mitotic kinesin inhibitors |
| 09/16/2004 | WO2004056322A3 Antibiotics containing borinic acid complexes and methods of use |
| 09/16/2004 | WO2004054637A3 Contrast media formulations having improved biological tolerance |
| 09/16/2004 | WO2004052278A3 Escape mutants of newcastle disease virus as marker vaccines |
| 09/16/2004 | WO2004047762A3 Methods for treating cancer using porimin as a target |
| 09/16/2004 | WO2004047753A3 Freeze-drying microscope stage apparatus and process of using the same |
| 09/16/2004 | WO2004047730A3 Compounds for inhibition of hiv infection by blocking hiv entry |
| 09/16/2004 | WO2004037211A3 Taxane metabolites |
| 09/16/2004 | WO2004037203A3 Sustained release l-arginine formulations and methods of manufacture and use |
| 09/16/2004 | WO2004035005A3 Three layer tear formulation |
| 09/16/2004 | WO2004030631A3 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 09/16/2004 | WO2004016230A3 Identification of the endothelial receptor for the angiostatin kringle-5 |
| 09/16/2004 | WO2004012655A3 Anti-microbial compositions and methods of using same |
| 09/16/2004 | US20040181429 Method and system for administering a drug |
| 09/16/2004 | US20040180969 Phosphoric ester demulsifier composition |
| 09/16/2004 | US20040180964 anti-obestic activity; Neuropeptide Y antagonist |
| 09/16/2004 | US20040180947 Sulfonamide compounds and pharmaceutical use thereof |
| 09/16/2004 | US20040180944 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction |
| 09/16/2004 | US20040180932 Benzothiophenes, formulations containing same, and methods |
| 09/16/2004 | US20040180906 Anti-inflammatory medicaments |
| 09/16/2004 | US20040180896 P38 inhibitors and methods of use thereof |
| 09/16/2004 | US20040180894 Benzamide inhibitors of the P2X7 receptor |
| 09/16/2004 | US20040180892 control of cardiovascular homeostasis is achieved through a combination of both direct neuronal control and systemic neurohormonal activation |
| 09/16/2004 | US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/16/2004 | US20040180875 Obesity, anorexia, bulemia, depression, anxiety, psychosis, schizophrenia, migraine, addictive behavior, obsessive-compulsive disorder, sexual disorders |
| 09/16/2004 | US20040180853 Allantoin-containing skin cream |
| 09/16/2004 | US20040180841 Enhanced cancer selectivity; compounds having at least one hydroxyl group replaced with alternate functionality |
| 09/16/2004 | US20040180838 Effective against trypanosoma brucei rhodiense and leishmania donovani |
| 09/16/2004 | US20040180828 Apoptosis suppression; polypeptides of sequence 2 having surface groove including amino acid residues P325, G326, H343 and L344 |
| 09/16/2004 | US20040180822 Pretreating prior to insertion during tissue repair surgery; promoting healing |
| 09/16/2004 | US20040180419 by combining protein replacement therapy with active site-specific chaperones (ASSC) to increase the stability and efficiency of the protein being administered |
| 09/16/2004 | US20040180105 Use of a Ginkgo biloba extract for preparing a medicament intended to ease the withdrawal of individuals dependent on the consumption of alcohol, amphetamines, tobacco, drugs inducing toxicomania |
| 09/16/2004 | US20040180101 Topical pain relieving product |
| 09/16/2004 | US20040180059 For alleviating symptoms of systemic lupus erythematosus (SLE) in a human subject |
| 09/16/2004 | US20040180058 Vaccine compositions and methods |
| 09/16/2004 | US20040180015 Also containing an alpha hydroxyl acid or phosphoric acid |
| 09/16/2004 | CA2518237A1 Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 09/16/2004 | CA2518119A1 Trans-membrane-antibody induced inhibition of apoptosis |
| 09/16/2004 | CA2517886A1 Diphenylethylene compounds and uses thereof |
| 09/16/2004 | CA2517884A1 Aerosol antiperspirant with polyamide |
| 09/16/2004 | CA2517767A1 Ligands that bind to the amyloid-.beta. precursor peptide and related molecules and uses thereof |
| 09/16/2004 | CA2517525A1 Posh interacting proteins and related methods |
| 09/16/2004 | CA2517523A1 Substituted thiophenes with antibacterial activity |
| 09/16/2004 | CA2517461A1 Pyridinium salts, compounds and methods of use |
| 09/16/2004 | CA2517166A1 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists |